Kristen Brennand, PhD

Dr. Brennand is a Professor at the Yale School of Medicine where her research focuses on schizophrenia, a debilitating psychiatric disorder with no cure. She works with human stem cell-based models to study predisposition to neuropsychiatric diseases, applying innovative strategies including CRISPR gene editing to systematically test the impact of causal disease variants in human cells. She completed her postdoctoral research at the Salk Institute for Biological Studies.

• PubMed Profile
• Dr. Brennand's Lab Website

• Neurobiology

• NYSCF Community Showcased at the International Society for Stem Cell Research Conference
• Experts Unpack the First Stem Cell Model Study of PTSD and What it Means for Better Treatments
• The NYSCF Conference Returns in Person to Showcase Seminal Advances in Translational Stem Cell Research
• Stem Cell Study Reveals How Neurons From PTSD Patients React to Stress
• Toward Better Treatments for PTSD: Lessons Learned From The First-Ever Stem Cell Model of the Disorder
• Science by the Sea: Highlights of the NYSCF Innovators Retreat
• Juggling Motherhood, Mentorship, and Burnout During a Pandemic
• Tackling COVID, Promoting Health Equity, and Delivering on the Promise of Regenerative Medicine: Highlights of the 2020 NYSCF Conference
• Community Continues from Afar: Highlights of the NYSCF Innovators Retreat
• Science in the Time of COVID-19: Challenges, Opportunities, And the Path Forward
• How ‘Remixing’ a Gene May Lead to Schizophrenia and other Neuropsychiatric Diseases
• Genetic Variants Synergize to Confer Schizophrenia Risk
• NYSCF Innovator Uses Stem Cells To Uncover Genetic Abnormalities in Schizophrenia
• NYSCF Innovator Highlights the Difficulties of Stem Cell Line Derivation
• Explaining Schizophrenia with Multiple Genes
• NYSCF Innovator Sheds Light on Genetic Risk for Schizophrenia
• Stem Cells Help Researchers Understand Schizophrenia